Diffuse large B-cell lymphoma trials in Türkiye
7 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 3RecruitingTrial-stage medicine
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
- Where
- Ankara, Istanbul, Izmir, Mezitli, Sakarya, Samsun, Tekirdağ, Yenimahalle
- Age
- 18 years and over
- People
- 904 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06091865EU 2022-502785-25-00Registry updated 2026-11-04
Phase 2/3RecruitingTrial-stage medicine
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
- Where
- Ankara, Bornova, Istanbul, Izmir, Samsun, Yenimahalle
- Age
- 18 years and over
- People
- 290 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05139017EU 2022-502646-27-00Registry updated 2026-11-03
Phase 1/2RecruitingTrial-stage medicine
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Ankara, Bornova
- Age
- 6 months to 25 years
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103EU 2023-507178-41-00Registry updated 2026-10-30
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- Where
- Adana, Ankara, Antalya, Istanbul, Korfez Mahallesi, Suleymanpasa
- Age
- 18 years and over
- People
- 1,046 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06717347EU 2024-515566-13-00Registry updated 2026-10-21
Phase 1/2RecruitingTrial-stage medicine
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Where
- Balçova, Kayseri, Sakarya, Samsun
- Age
- 18 years and over
- People
- 689 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT05006716EU 2022-502157-33-00Registry updated 2026-10-05
No phaseRecruitingResearch participation
A Multicenter Observational Study to Understand the Clinical Characteristics, Treatment Patterns and Access to Novel Therapies of Patients With Diffuse Large B-Cell Lymphoma in the MEA Region
- Where
- Ankara, Antalya, Istanbul, Izmir
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07065344Registry updated 2026-09-23
Phase 2RecruitingTrial-stage medicine
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
- Where
- Ankara, Şişli, Zeytinburnu
- Age
- 18 years to 70 years
- People
- 213 worldwide
- Run by
- Miltenyi Biomedicine GmbH
See details and how to joinNCT04844866EU 2023-506270-13-00Registry updated 2026-06-10
All Diffuse large B-cell lymphoma trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.